Ali Arıcan

422 total citations
37 papers, 226 citations indexed

About

Ali Arıcan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Ali Arıcan has authored 37 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Ali Arıcan's work include Viral-associated cancers and disorders (7 papers), Cancer Diagnosis and Treatment (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Ali Arıcan is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Cancer Diagnosis and Treatment (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Ali Arıcan collaborates with scholars based in Türkiye, Iran and Switzerland. Ali Arıcan's co-authors include Erdinç Nayır, Mehmet Haberal, Dìlek Dìnçol, H. Karakayalı, Fikri İçlı, Hakan Akbulut, Ahmet Demirkazık, Ahmet Kıykım, Beyhan Demirhan and Özden Uzunalımoǧlu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Ali Arıcan

36 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Arıcan Türkiye 10 128 67 49 47 37 37 226
Alberto Romero Argentina 10 228 1.8× 71 1.1× 92 1.9× 49 1.0× 59 1.6× 19 352
Fuat Demirelli Türkiye 11 135 1.1× 58 0.9× 97 2.0× 83 1.8× 13 0.4× 34 296
Bong-Seog Kim South Korea 10 121 0.9× 60 0.9× 130 2.7× 22 0.5× 51 1.4× 15 296
Joo Young Jung South Korea 11 150 1.2× 86 1.3× 138 2.8× 19 0.4× 19 0.5× 41 300
Takatsugu Ogata Japan 8 156 1.2× 57 0.9× 107 2.2× 19 0.4× 27 0.7× 45 229
Ömer Fatih Ölmez Türkiye 9 161 1.3× 48 0.7× 56 1.1× 14 0.3× 46 1.2× 52 284
Jwa Hoon Kim South Korea 11 182 1.4× 81 1.2× 112 2.3× 74 1.6× 36 1.0× 30 348
Tijani El Harroudi Morocco 8 115 0.9× 63 0.9× 50 1.0× 29 0.6× 29 0.8× 65 228
Luis Miguel Juárez‐Salcedo Spain 7 102 0.8× 28 0.4× 59 1.2× 108 2.3× 31 0.8× 24 325
Anette von Rosen Sweden 11 179 1.4× 63 0.9× 71 1.4× 38 0.8× 39 1.1× 22 339

Countries citing papers authored by Ali Arıcan

Since Specialization
Citations

This map shows the geographic impact of Ali Arıcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Arıcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Arıcan more than expected).

Fields of papers citing papers by Ali Arıcan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Arıcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Arıcan. The network helps show where Ali Arıcan may publish in the future.

Co-authorship network of co-authors of Ali Arıcan

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Arıcan. A scholar is included among the top collaborators of Ali Arıcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Arıcan. Ali Arıcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gültekin, Serap, Cihan Uras, Fatma Tokat, et al.. (2023). False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status. Acta Oncologica Turcica. 56(2). 97–105. 1 indexed citations
2.
Yıldız, İbrahim, Sibel Erdamar, Süha Göksel, et al.. (2019). Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDl-1 expression in Turkish patients with gastric cancer.. Journal of Clinical Oncology. 37(15_suppl). e15538–e15538. 1 indexed citations
3.
Beşen, Ali Ayberk, et al.. (2014). Lack of Prognostic Significance of C-erbB-2 Expression in Low- and High- grade Astrocytomas. Asian Pacific Journal of Cancer Prevention. 15(3). 1333–1337. 6 indexed citations
4.
Polat, Ayşe, et al.. (2014). Prognostıc Value of Increased her2 Expression in Cancers of Pancreas and Biliary Tree. Pathology & Oncology Research. 21(3). 831–838. 11 indexed citations
5.
Mertsoylu, Hüseyin, Ali Ayberk Beşen, Ahmet Sezer, et al.. (2014). Primary Extranodal Non-Hodgkin's Lymphoma: Clinicopathological Features, Survival and Treatment Outcome in Two Cancer Centers of Southern Turkey. Asian Pacific Journal of Cancer Prevention. 15(17). 7207–7211. 7 indexed citations
6.
Nayır, Erdinç, et al.. (2014). Impact of Surgery Type on Quality of Life in Breast Cancer Patients. SHILAP Revista de lepidopterología. 10(4). 222–228. 27 indexed citations
7.
Arıcan, Ali, Hakan Bozcuk, Süleyman Buyukberber, et al.. (2014). A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey. Supportive Care in Cancer. 22(10). 2629–2634. 6 indexed citations
8.
Türker, İbrahim, Şeref Kömürcü, Ali Arıcan, et al.. (2014). Investigational tests and treatments performed in terminal stage cancer patients in two weeks before death: Turkish oncology group (TOG) study. Medical Oncology. 31(12). 350–350. 1 indexed citations
9.
Arpacı, Rabia Bozdoğan, et al.. (2013). Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors. Pathology - Research and Practice. 209(7). 413–417. 11 indexed citations
10.
Arıcan, Ali, et al.. (2012). Kanser Tedavisinde Kullanılan İlaçlar Ve Nefrotoksisite. DergiPark (Istanbul University). 1 indexed citations
11.
Demirkazık, Ahmet, et al.. (2004). Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer. Annals of Saudi Medicine. 24(6). 473–475. 2 indexed citations
12.
Akçay, Şule, Füsun Öner Eyüboğlu, Ali Arıcan, & Beyhan Demirhan. (2001). Effect of pulse steroid therapy in a patient with Langerhans’ cell histiocytosis. Respirology. 6(4). 357–360. 1 indexed citations
13.
Güz, Galip, et al.. (2000). Two renal transplants from one cadaveric donor: one recipient with simultaneous B cell lymphoma and Kaposi's sarcoma, and the other with T cell lymphoma. Nephrology Dialysis Transplantation. 15(8). 1242–1244. 5 indexed citations
14.
Arıcan, Ali, et al.. (2000). Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma. Medical Oncology. 17(2). 123–126. 19 indexed citations
15.
Arıcan, Ali, et al.. (1999). Philadelphia chromosome (+) T-cell acute lymphoblastic leukemia after renal transplantation. Transplantation Proceedings. 31(8). 3242–3243. 4 indexed citations
16.
Dìnçol, Dìlek, Ali Arıcan, Arzu Ensarı, et al.. (1999). Concurrent occurrence of three neoplasms including non-Hodgkin’s lymphoma, renal cell carcinoma and leiomyoma in the same kidney. Medical Oncology. 16(2). 134–138. 9 indexed citations
17.
Güz, Galip, Ali Arıcan, H. Karakayalı, et al.. (1999). Simultaneous non-Hodgkin’s and Kaposi’s sarcoma in a renal transplant recipient. Transplantation Proceedings. 31(8). 3240–3241. 3 indexed citations
18.
Arıcan, Ali, Fikri İçlı, Hakan Akbulut, et al.. (1999). The effect of two different doses of oral clodronate on pain in patients with bone metastases. Medical Oncology. 16(3). 204–210. 13 indexed citations
19.
İçlı, Fikri, et al.. (1999). Phase II Study of Cisplatin and Dacarbazine for Metastatic Colorectal Carcinoma Resistant to 5-Fluorouracil. Oncology. 56(4). 297–300. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Romero Breakdown of academic impact, for papers by Fuat Demirelli Breakdown of academic impact, for papers by Bong-Seog Kim Breakdown of academic impact, for papers by Joo Young Jung Breakdown of academic impact, for papers by Takatsugu Ogata Breakdown of academic impact, for papers by Ömer Fatih Ölmez Breakdown of academic impact, for papers by Jwa Hoon Kim Breakdown of academic impact, for papers by Tijani El Harroudi Breakdown of academic impact, for papers by Luis Miguel Juárez‐Salcedo Breakdown of academic impact, for papers by Anette von Rosen
Rankless by CCL
2026